ACTIVE PROJECTS
Ongoing projects in 2018
242NATIONALS
84INTERNATIONALS
32,260,915.38€NATIONAL FUNDING
15,839,020.23€INTERNATIONAL FUNDING
48.1M€TOTAL FUNDING
National Projects
| AGAUR | 2 |
|---|---|
| Agència Competitivitat Empresa Catalana ACCIO | 5 |
| Asociación Española Contra el Cáncer | 8 |
| ASOCIACION ESPAÑOLA GASTROENTEROLOGIA | 1 |
| CERCA (Centres de Recerca de Catalunya) | 2 |
| Fundació “La Caixa” | 4 |
| Fundació La Marató de TV3 | 24 |
| Fundació Privada Daniel Bravo Andreu | 1 |
| Fundació Santiago Dexeus Font | 1 |
| Fundación AECP | 1 |
| Fundación Innov. y Prosp. Salud en España – FIPSE | 1 |
| Fundación Invest. Médica Mutua Madrileña | 3 |
| Fundación Sdad Española Alergología e Inmunología | 1 |
| Fundación SEIMC-GESIDA | 1 |
| Generalitat de Catalunya – Departament de Salut | 12 |
| Gilead Sciences SL | 4 |
| Grifols S.A. | 1 |
| Grupo Español Investigación Sarcomas (GEIS) | 1 |
| Instituto de Salud Carlos III | 139 |
| Ministerio Economía, Industria y Competitividad | 19 |
| Ministerio Sanidad Servicios Sociales e Igualdad | 4 |
| Mutual Mèdica de Catalunya i Balears | 1 |
| Soc.Española Neumologia Cirugia Toracica | 1 |
| Sociedad Española de Cardiologia | 2 |
| Societat Catalana de Cardiologia | 1 |
| Societat Catalana de Pneumologia | 1 |
| Societat Catalana d’Endocrinologia i Nutrició | 1 |
| TOTAL | 242 |
International Projects
| American Association for Cancer Research | 1 |
|---|---|
| Brain & Behavior Research Foundation | 1 |
| BrightFocus Foundation | 1 |
| Canadian Institutes of Health Research | 3 |
| European Commission | 34 |
| Programación Conjunta (European Commission-ISCIII) | 9 |
| European Cystic Fibrosis Society | 1 |
| European Foundation for the Study of Diabetes | 1 |
| European Soc.Clinical Microbiology and Infect Dise | 1 |
| EUROSPINE | 1 |
| Ex. Agency for Health Consumers (EAHC)-CHAFEA | 3 |
| Gilead Sciences SL | 3 |
| Innovative Therapies Children Cancer (ITCC) | 1 |
| Michael J. Fox Foundation | 3 |
| National Institutes of Health (NIH) | 7 |
| NuVasive INC | 1 |
| Pfizer Inc | 1 |
| Pfizer Limited | 2 |
| St. Michael’s Hospital | 2 |
| The Crohn’s & Colitis Foundation of America | 1 |
| The Innovative Medicines Initiative | 6 |
| University of Calgary | 1 |
| TOTAL | 84 |
Ongoing research projects according to Research Area
| Oncology | 51 |
|---|---|
| Vascular Biology and Metabolism (VAM) | 70 |
| Neurosciences | 68 |
| Infectious Diseases | 37 |
| Digestive and Liver Diseases | 30 |
| SICARDPATH | 26 |
| Research in Surgery | 16 |
| Obstetrics. Pediatrics and Genetics | 11 |
| Experimental Hematology | 1 |
| Others | 16 |
| TOTAL | 326 |
NEW RESEARCHERS
Research positions granted
| SENIOR RESEARCHERS | |
| Miguel Servet Programme II_(ISCIII) | 4 |
|---|---|
| Strengthening of research activity Programme _(ISCIII) | |
| POSTDOCTORAL RESEARCHERS | |
| Incorporación Científics_Peris (GENCAT) | 7 |
| POST-MIR RESEARCHERS | |
| Juan Rodés Programme_(ISCIII) | 1 |
| Río Hortega Programme_(ISCIII) | 4 |
| Juan de la Cierva_Incorporació (MINECO) | 0 |
| PREDOCTORAL RESEARCHERS | |
| Rio Hortega_(ISCIII) | 4 |
| Predoc _FI + iIFI_(ISCIII) | 7 |
| RESEARCH STAFF SUPPORT | |
| Mobilitats_(ISCIII) | 2 |
| Intensificacions_(ISCIII) | 1 |
| Técnic Suport_(MINECO) | 0 |
| Intensificacions_Peris_(GENCAT) | 6 |
| Estades_(MECD) | 1 |
| TOTAL | 37 |
CIBER
List of CIBER (Network Biomedical Research Center) projects with VHIR involvement
| TITLE | PROJECT MANAGER | RESEARCH GROUP |
|---|---|---|
| CIBER-BBN | Schwartz Navarro, Simó | CIBBIM-Nanomedicine Drug Delivery and Targeting |
| CIBERESP | Ferreira González, Ignacio | Cardiocirculatory Pathology |
| CIBEREHD | Esteban Mur, Juan Ignacio | Liver Diseases |
| CIBEREHD | Esteban Mur, Rafael | Liver Diseases |
| CIBEREHD | Guarner Aguilar, Francisco | Physiology and Pathophysiology of the Digestive Tract |
| CIBEREHD | Azpiroz Vidaur, Fernando | Physiology and Pathophysiology of the Digestive Tract |
| CIBEREHD | Genescà Ferrer, Joan | Liver Diseases |
| CIBERRES | Muñoz Gall, Xavier | Pneumology |
| CIBERRES | Rello Coromines, Jordi | Clinical Research / Innovation in Pneumonia & Sepsis (CRIPS) |
| CIBERER | Carrascosa, Antonio | Growth and Development |
| CIBERER | Martí Seves, Ramón | Neuromuscular and Mitochondrial Pathology |
| CIBERDEM | Simó Canonge, Rafael | Diabetes and Metabolism |
| CIBERNED | Comella Carnice, Joan X. | Cell Signaling and Apoptosis |
| CIBERNED | Vila Bover, Miquel | Neurodegenerative Diseases |
| CIBERSAM | Casas Brugué, Miquel | Psichiatry, Mental Health and Addictions |
| CIBER Cardiovascular Diseases | García-Dorado García, David | Cardiovascular Diseases |
| CIBERONC | Ramon y Cajal Agüeras, Santiago | Translational Molecular Pathology |
NETWORKS
List of ISCIII thematic network centers that the vhir is involved in
| Network | Project Manager | Duration |
|---|---|---|
| European Network on Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (EUROMENE) | Castro Marrero, Jesus | 21/04/2016-20/04/2020 |
| RETICS – Enfermedades Infecciosas | Almirante Gragera, Benito | 01/01/2017-31/12/2021 |
| RETICS – Enfermedades Renales | Serón Micas, Daniel | 01/01/2017 – 31/12/2021 |
| RETICS – SIDA | Ribera Pascuet, Esteve | 01/01/2017-31/12/2021 |
| RETICS – Enfermedades Tropicales | Molina Romero, Israel | 01/01/2017-31/12/2021 |
| RETICS – Enfermedades Vasculares Cerebrales (Ictus) | Montaner Villalonga, Joan | 01/01/2017-31/12/2021 |
| RETICS – Enfermedades oculares | García Arumí, José | 01/01/2017-31/12/2021 |
| RETICS -Esclerosis Múltiple | Comabella Lopez, Manuel | 01/01/2017-31/12/2021 |
| RETICS – Reacciones Adversas a Alérgenos y Fármacos | Labrador Horrillo, Moisés | 01/01/2017-31/12/2021 |
| RETICS – Salud Materno-Infantil y del Desarrollo | Llurba Olivé, Elisa | 01/01/2017-31/12/2021 |
| Plataforma Red Nacional de Biobancos | Novoa Garcia, Isabel | 01/01/2014-31/12/2018 |
| Plataforma Red Nacional de Biobancos | Novoa Garcia, Isabel | 01/01/2018-31/12/2021 |
| Plataforma de Innovación en Tecnologías Médicas y Sanitarias (ITEMAS) | Riera Guerra, Anna | 01/01/2018-31/12/2021 |
| Plataforma d’innovació en tecnologies mèdiques i sanitàries | Comella Carnice, Joan Xavier | 01/01/2014-31/12/2018 |
| Plataforma Unidades de Investigación Clínica y Ensayos Clínicos | Fuentes Camps, Inmaculada | 01/01/2014-31/12/2018 |
| RED DE INVESTIGACION EN NRF2 COMO NODO DEL PATOGENOSOMA, en col·laboració amb la Universidad Autónoma de Madrid | Montaner Villalonga, Joan | 01/01/2016-01/01/2018 |
| Spanish Clinical Research Network (SCReN) | Fuentes Camps, Inmaculada | 01/01/2018-31/12/2021 |
List of VHIR research groups recognized by the “Generalitat de Catalunya”
GRC – Consolidated Group
GRE – Emergent Group
| File | Project Manager | Duration |
|---|---|---|
| Grups de recerca en Imatge Mèdica Molecular | Raúl Herance | 01/01/2017-31/12/2020 |
| CIBBIM – Nanomedicine. Biomedical Research Digestive Tract Tumors | Fernando Azpiroz | 01/01/2017-31/12/2020 |
| Comparative effects of encapsulated antagomir 92a vs not encapsulated on inhibition of miR-92a in myocardial tissue following a short duration of post-MI reperfusion | David García Dorado | 01/01/2017-31/12/2020 |
| Infectious Diseases | Benito Almirante | 01/01/2017-31/12/2020 |
| Lewy body extracts from parkinson’s disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys | Miquel Vila | 01/01/2017-31/12/2020 |
|
Neurovascular diseases |
Anna Rosell | 01/01/2017-31/12/2020 |
| Clinical neuroimmunology. Centre d’Esclerosi Multiple de Catalunya (CEMCAT) | Xavier Montalbán | 01/01/2017-31/12/2020 |
| Psychiatry, mental health and addictions | Miquel Casas | 01/01/2017-31/12/2020 |
| Headache Research Group | Patricia Pozo | 01/01/2017-31/12/2020 |
| Pneumology Research group | Jaume Ferrer | 01/01/2017-31/12/2020 |
| Biomedical Research in Gynecology | Antonio Gil | 01/01/2017-31/12/2020 |
| Apoptosis and Neurodegeneration | Joan X. Comella | 01/01/2017-31/12/2020 |
|
Shock, Organ Dysfunction & Resuscitation |
Ricard Ferrer | 01/01/2017-31/12/2020 |
|
Liver diseases |
Joan Genescà | 01/01/2017-31/12/2020 |
|
Diabetes and Metabolism |
Rafa Simó | 01/01/2017-31/12/2020 |
|
Infection in immunocompromised pediatric patients |
Pere Soler | 01/01/2017-31/12/2020 |
|
Epilepsy Group Vall d’Hebron University Hospital |
Estevo Santamarina | 01/01/2017-31/12/2020 |
|
General Surgery |
Manel Armengol i Carrasco | 01/01/2017-31/12/2020 |
|
CIBBIM- Nanomedicine. Drug Delivery and Targeting |
Simo Schwartz | 01/01/2017-31/12/2020 |
|
Musculoskeletal Tissue Engineering |
Màrius Aguirre Canyadell | 01/01/2017-31/12/2020 |
|
Clinical pharmacology |
Luisa Ibáñez | 01/01/2017-31/12/2020 |
|
Cellular Pathology |
Anna Meseguer | 01/01/2017-31/12/2020 |
|
Autoinmunity and Thrombotic Diseases |
Albert Selva | 01/01/2017-31/12/2020 |
|
Fetal Maternal Medicine |
Elena Carreras | 01/01/2017-31/12/2020 |
|
Pediatric neurology |
Alfons Macaya | 01/01/2017-31/12/2020 |
|
Ophthalmology |
Josep García-Arumí | 01/01/2017-31/12/2020 |
|
Translational Molecular Pathology |
Santiago Ramón y Cajal | 01/01/2017-31/12/2020 |
|
Neuromuscular and mitochondrial pathology |
Ramon Martí | 01/01/2017-31/12/2020 |
|
Biomedical Research in Cancer Stem Cells |
Matilde Lleonart | 01/01/2017-31/12/2020 |
|
Clinical Research and Epidemiology in Pneumonia & Sepsis (CRIPS) |
Jordi Rello | 01/01/2017-31/12/2020 |
|
Spine Research Unit |
Ferrran Pellisé | 01/01/2017-31/12/2020 |
|
Neurotraumatology and neurosurgery research group unit (UNINN) |
Juan Sahuquillo | 01/01/2017-31/12/2020 |
|
Group of Biomedical Research in Digestive Tract Tumors |
Diego Arango | 01/01/2017-31/12/2020 |
|
Translational Research in Child and Adolescent Cancer |
Josep Sánchez de Toledo | 01/01/2017-31/12/2020 |
|
Biomedical Research in Melanoma – Animal model and cancer |
Juan Recio | 01/01/2017-31/12/2020 |
|
Growth and Development |
Antonio Carrascosa | 01/01/2017-31/12/2020 |
|
Biomarquers and targets of resistant prostate cancer |
Rosanna Paciucci | 01/01/2017-31/12/2020 |
|
Clinical Microbiology Research Groups at the Vall d’Hebron University Hospital |
Tomàs Pumarola | 01/01/2017-31/12/2020 |
|
Vall d’Hebron Initiative for Regenerative Medicine |
J. P. Barret | 01/01/2017-31/12/2020 |
|
Bioengineering, Orthopedics and Pediatric Surgery |
César Galo García Fontecha | 01/01/2017-31/12/2020 |
|
Immunobiology |
Joan Sayós | 01/01/2017-31/12/2020 |
|
CIBBIM – Nanomedicine. Diagnostic nanotools (DINA Tools) |
Eva Baldrich | 01/01/2017-31/12/2020 |
Granted Projects
| National | Number of granted projects |
|---|---|
| AGAUR | 3 |
| Asociación Española Contra el Cáncer | 2 |
| ASOCIACION ESPAÑOLA GASTROENTEROLOGIA | 1 |
| CERCA (Centres de Recerca de Catalunya) | 1 |
| COL·LEGI PROFESSIONAL FISIOTERAPEUTES DE CATALUNYA | 1 |
| Fundació “La Caixa” | 3 |
| Fundació La Marató de TV3 | 5 |
| Fundación Asociación Española de Pediatría | 1 |
| Fundación Invest. Médica Mutua Madrileña | 1 |
| Fundación LEITAT | 1 |
| Fundación Mari Paz Jimenez Casado | 1 |
| Fundación Ramón Areces | 1 |
| Fundación SEIMC-GESIDA | 1 |
| Generalitat de Catalunya – Departament de Salut | 1 |
| Gilead Sciences SL | 4 |
| Instituto de Salud Carlos III | 40 |
| Ministerio Economía, Industria y Competitividad | 3 |
| Sociedad Española de Cardiologia | 1 |
| Sociedad Española de Cirugía de Obesidad | 1 |
| Societat Catalana de Pneumologia | 1 |
| CSL Behring, S.A. | 2 |
| Programación Conjunta Internacional (ISCIII-European Commission) | 2 |
| TOTAL | 77 |
| International | Number of granted projects |
|---|---|
| European Commission | 8 |
| European Society for Immunodeficiencies | 1 |
| Michael J. Fox Foundation | 2 |
| National Health and Medical Res Council (NHMR | 1 |
| NuVasive INC | 1 |
| Pfizer Limited | 1 |
| The Innovative Medicines Initiative | 3 |
| TOTAL | 17 |
